With the latest series B funding, led by RA Capital Management and Polaris Partners, Freenome’s total financing reached to $238m (£190.8m). The funding round saw participation from the
The post Freenome secures £128m funds for multiomics cancer blood testing platform appeared first on NS Medical Devices.